pETcon-pGAL1-Aga2-Htt(25Q)-c_myc
(Plasmid
#225228)
-
PurposeYeast optimized human Htt (25Q) fused with aga2 protein gene under gal1 promoter for the expression of Htt (25Q) in yeast surface display.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 225228 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepETcon(-)
- Backbone size w/o insert (bp) 5740
- Total vector size (bp) 6415
-
Vector typeYeast Expression
-
Selectable markersTRP1
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert nameAga2
-
SpeciesS. cerevisiae (budding yeast)
-
Insert Size (bp)261
-
GenBank ID852851
-
Tag
/ Fusion Protein
- HA Tag (N terminal on insert)
Gene/Insert 2
-
Gene/Insert nameHtt (25Q)
-
SpeciesH. sapiens (human)
-
Insert Size (bp)276
-
GenBank ID3064
-
Tag
/ Fusion Protein
- c-myc Tag (N terminal on insert)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pETcon-pGAL1-Aga2-Htt(25Q)-c_myc was a gift from Urartu Seker (Addgene plasmid # 225228 ; http://n2t.net/addgene:225228 ; RRID:Addgene_225228) -
For your References section:
Highly Potent Peptide Therapeutics To Prevent Protein Aggregation in Huntington's Disease. Khan A, Ozcelik CE, Begli O, Oguz O, Kesici MS, Kasirga TS, Ozcubukcu S, Yuca E, Seker UOS. ACS Med Chem Lett. 2023 Nov 14;14(12):1821-1826. doi: 10.1021/acsmedchemlett.3c00415. eCollection 2023 Dec 14. 10.1021/acsmedchemlett.3c00415 PubMed 38116434